- Home
- ADPT vs MSC Comparison
ADPT vs MSC Comparison
Compare ADPT & MSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADPT
- MSC
- Stock Information
- Founded
- ADPT 2009
- MSC 2000
- Country
- ADPT United States
- MSC Hong Kong
- Employees
- ADPT N/A
- MSC N/A
- Industry
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- MSC Hotels/Resorts
- Sector
- ADPT Health Care
- MSC Consumer Discretionary
- Exchange
- ADPT Nasdaq
- MSC Nasdaq
- Market Cap
- ADPT 1.2B
- MSC 1.0B
- IPO Year
- ADPT 2019
- MSC 2018
- Fundamental
- Price
- ADPT $8.27
- MSC $3.98
- Analyst Decision
- ADPT Buy
- MSC
- Analyst Count
- ADPT 5
- MSC 0
- Target Price
- ADPT $9.10
- MSC N/A
- AVG Volume (30 Days)
- ADPT 1.4M
- MSC 13.7K
- Earning Date
- ADPT 02-11-2025
- MSC 03-03-2025
- Dividend Yield
- ADPT N/A
- MSC N/A
- EPS Growth
- ADPT N/A
- MSC N/A
- EPS
- ADPT N/A
- MSC N/A
- Revenue
- ADPT $178,957,000.00
- MSC $627,533,000.00
- Revenue This Year
- ADPT $20.07
- MSC $33.86
- Revenue Next Year
- ADPT $25.27
- MSC $16.73
- P/E Ratio
- ADPT N/A
- MSC N/A
- Revenue Growth
- ADPT 5.10
- MSC 103.40
- 52 Week Low
- ADPT $2.28
- MSC $3.50
- 52 Week High
- ADPT $8.95
- MSC $9.30
- Technical
- Relative Strength Index (RSI)
- ADPT 58.94
- MSC 43.63
- Support Level
- ADPT $8.09
- MSC $3.50
- Resistance Level
- ADPT $8.69
- MSC $4.34
- Average True Range (ATR)
- ADPT 0.64
- MSC 0.41
- MACD
- ADPT -0.00
- MSC 0.06
- Stochastic Oscillator
- ADPT 65.66
- MSC 33.10
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About MSC Studio City International Holdings Limited
Studio City International Holdings Ltd is a gaming, retail, and entertainment resort located in Cotai, Macau. It operates Studio City Casino with around 250 mass-market gaming tables; including 15 tables for VIP rolling chip operations, and 552 gaming machines. Studio City features luxury hotel rooms, diverse food and beverage establishments, and complementary retail space. In addition, the company offers non-gaming attractions, including the world's first figure-8 Ferris wheel, a deluxe nightclub and karaoke venue, a live performance arena, an outdoor and an indoor water park. Geographically, the company derives the majority of its revenue from the Macau region.